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Abstract Our objectives were to compare people with
epilepsy (PWE) who died of sudden unexpected death in
epilepsy (SUDEP) with live controls using the risk factor
items of the SUDEP and Seizure Safety Checklist. All 48
SUDEPs of 93 epilepsy deaths which occurred in Cornwall
UK 2004–2012 were compared to 220 live controls using
the SUDEP and Seizure Safety Checklist, an evidenced
based tool used to communicate person centered risk of
SUDEP to PWE. The odds ratio for having a specific factor
in those who died was compared to controls and ranked
according to P value using a sequential Bonferroni cor-
rection for multiple comparisons. Of the 17 modifiable and
non-modifiable risk factors analyzed 9 were statistically
significant of which 7 are potentially modifiable. Well
known modifiable factors such as nocturnal monitoring,
compliance and sleeping position featured prominently in
the risk association. This is the first case control study
exploring the risk factors for SUDEP since 2009. The
findings are compared to the current considered risk factors
as identified in a major recent review. The study further
validates certain SUDEP risk factors. It highlights that the
majority of risk factors strongly associated with SUDEP
are potentially modifiable. There is an emerging profile to
rank the risk factors. It furthers the evidence to use struc-
tured risk assessment and communication tools such as the
SUDEP and Seizure Safety Checklist in daily clinical
practice. It highlights key areas for a person centered dis-
cussion to empower PWE to mitigate risk.
Keywords SUDEP  Case–control study  Risk factors 
Epilepsy deaths
Introduction
Sudden unexpected death in epilepsy (SUDEP) is the most
important direct cause of deaths in epilepsy [1]. People
with epilepsy (PWE) are 20 times more likely to die sud-
denly compared to the general population [2]. SUDEP is
the most common cause of death in PWE. In the UK in
2013, 1187 people died from epilepsy (includes SUDEP,
status, etc.), roughly the same amount of that died from
asthma (1255) despite there being a population of over 5.3
million people with asthma while PWE number around
600,000. The 2013 Office of National Statistics UK data
suggest that up to 60.5 % of these epilepsy deaths were
seen as avoidable, whereas 25.5 % of asthma deaths were.
This suggests that there may be improvement in the way
we identify risk and manage PWE in the community.
In the recent literature review on risk factors for SUDEP
[3], 20 factors were identified that increased the risk of
SUDEP. These 20 factors were subsequently applied to a
previously unexposed set of all SUDEPs (n = 48) extrac-
ted by going through all epilepsy deaths (n = 93) in the
county of Cornwall UK (population 550,000) between
2004 and 2012 to see if they remained consistent with the
literature review findings [4]. It was found that 17 factors
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remained well associated with SUDEP and are directly
relevant for people living with epilepsy. These 17 factors
forms the background of the seizure and SUDEP safety
checklist, a 10 min risk assessment tool used in epilepsy
clinics across UK and the self-monitoring of epilepsy risk
mobile app for smart phones in both android and Apple,
EpSMon [5–7]. We compared these 17 factors between the
48 subjects who died from SUDEP in Cornwall with 220 of
231 continuous patients living with epilepsy who attended
local outpatient epilepsy clinics to determine how strongly
these factors are associated with SUDEP risk in a well-
defined population.
Method
We compared data collected over nine continuous years of
SUDEPs at the Cornwall Coroner’s office using the
SUDEP and Seizure Safety Checklist [3, 4] with data from
medical records of clinical discussion with a full year of
most PWE attending local epilepsy outpatient clinics on the
potential risk factors identified for SUDEP using the same
checklist.
We systemically inspected all epilepsy and epilepsy
associated deaths which occurred in Cornwall between
2004 and 2012 all made available to us by the HM
Cornwall coroner. These are the deaths where epilepsy
was a primary or a secondary cause. The Cornwall
coroner’s office has a computerized system with a search
engine to explore all registered death certificates. The data
were collected from the coroner’s records using the terms
‘ep’, ‘epilepsy’, ‘seizures’, ‘fits’, ‘sudden death’ and
‘SUDEP’ in either part 1 or 2 of the death certificate.
Ninety-three deaths were thus identified by the coroner’s
office. Each death’s case file which included all com-
prehensive medical records up to the point of death was
reviewed to ascertain those deaths which met the SUDEP
criteria and classification using the operational definition
of SUDEP provided by Nashef and Anneger [4, 8]. Of the
93 cases of epilepsy-related deaths which occurred in
Cornwall between 2004 and 2012, forty eight cases met
the criteria for SUDEP. We cross-referenced the epilepsy
deaths of these years (2004–2012) with public health data
on epilepsy deaths held by the Public Health Department
of Cornwall. The public health data showed 73 epilepsy
deaths (43 male and 30 females) for the period of
2006–2012. This is in keeping with our estimates for that
period. The public health data only had the year, number
of deaths and sex recorded. We then applied the clinical
risk factors of the SUDEP and Seizure Safety Checklist to
all the SUDEP deaths. The detailed definitions used for
the risk factors are described in previous papers [3, 4, 6]
and Table 1.
The control population attended two specialist epilepsy
outpatient clinics in Cornwall and for whom the seizure
safety and SUDEP checklist [3, 5–7] was administered as
part of routine clinical practice over 1 year. The population
was a continuous sample. Of 231 attendees in the 1 year
(05/2013–05/2014) to the two clinics. Two hundred and
twenty consented to the use of the checklist. One year was
chosen to sample the whole clinic population as maximum
follow up time is 1 year.
We calculated the odds ratio for having a specific factor
in those who died from SUDEP compared to controls. We
ranked the factors according to P value and used a
sequential Bonferroni to correct for multiple comparisons.
Low numbers and missing data prevented a logistic
regression analysis.
Results
The United Kingdom (UK) has a population of about 60
million. Cornwall is a county in UK with a population of
600,000 (about 1 % of the UK population). It is largely a
rural county and not subject to major immigration/emi-
gration (except for large number of tourists during sum-
mer). The incidence of SUDEP has been estimated as
0.1 % of all people diagnosed with epilepsy per year
though it can raise to 1 in 150 PWE in refractory cases. An
estimated 600 deaths occur in a year due to SUDEP in the
UK, and thus Cornwall would be expected to have
approximately six SUDEP deaths a year. Our study is
consistent with these numbers as 48 deaths over 9 years
represent a rate of 5.33 SUDEP deaths/year.
Our case sample was 48 people, 33 male and 15 female
who died from SUDEP in Cornwall UK over the 9 year
period [4]. Among the 48 deaths, the mean age was
42.5 years and median 42 years with a range of
2–82 years. Our control sample was 220 outpatients
attending epilepsy clinics within Cornwall of whom 115
were male and 105 female. Among the 220 people, the
mean age was 42.76 years and median 47.5 years with a
range of 9–86 years. The majority of the SUDEP cases had
been known to the local specialist epilepsy services
sometime in their lifetime. However, 80 % of the SUDEP
cases did not see a specialist in the year prior to death.
The comparison between the groups is given in Table 1
and illustrated in Fig. 1. Of the 17 risk factors, nine showed
a significant difference between the two groups. Two sig-
nificant risk factors—duration of epilepsy and diagnosis of
generalized tonic–clonic epilepsy—are not modifiable.
However, there were seven potentially modifiable risk
factors: unclear treatment history, poor adherence to
medication, subtherapeutic medication levels, alcohol
misuse, no night surveillance, sleeping in the prone
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Table 1 Univariate analysis
Rank Factor and its description Odds ratio 95 % CI P value
1 Sleeping in prone position
Independent risk factor evidenced by several studies including a systematic
review
The prone position is defined as lying on the belly, chest, or face, with or
without obstruction of the nose or mouth. Sleeping in the prone position or
remaining in a prone position post seizure is considered a risk
0.034 0.012, 0.094 \0.001*
2 Treatment history—unclear
This is defined as where the rationale for treatment in the last 6 months is not
supported by current clinical evidence base such as NICE. For example not
modifying AED treatment if someone has refractory epilepsy or not
considering referring to a comprehensive epilepsy center for a surgical
evaluation
0.03 0.01, 0.1 \0.001*
3 Generalized tonic–clonic epilepsy
Combined data from the previous four case–control studies found this is the
most important risk factor
0.03 0.01, 0.09 \0.001*
4 Increasing seizure frequency
Active seizures which in the last 6 months were noted to worsen in frequency
of[25 %
0.05 0.02, 0.14 \0.001*
5 Compliance issues
This factor is defined by finding of variable AED hair strand levels in SUDEP
group. Compliance issues were also assessed via patient reporting as
evidenced by medical records in both groups. Adherence issues (including
not picking up prescriptions) found as a factor across all epilepsy-related
deaths as increasing risk by 50 %
0.09 0.03, 0.23 \0.001*
6 Alcohol problem
Is defined as where there is a clinically definable alcohol disorder as
identified by the WHO ICD 10 diagnostic Manual. A systematic analysis of
epilepsy deaths confirmed this risk factor
0.10 0.04, 0.28 \0.001*
7 Subtherapeutic AED levels
Is a finding linked closely to compliance
0.08 0.025, 0.24 \0.001*
8 Night surveillance
Nocturnal seizures were shown to have a 4 fold increased risk. 60 % of all
SUDEPs in large control study. Nocturnal surveillance thus where present
is considered to be a protective factor
13.0 3.7, 45.26 \0.001*
9 Duration ([15 years)
This has been suggested by several studies, but not after multiple logistical
regression analysis for seizure frequency
0.22 0.10, 0.49 \0.001*
10 Early onset epilepsy
Where the onset of epilepsy is before the age of 15 years
0.40 0.18, 0.90 0.025
11 Frequent AED changes
This is defined as where the changes of dose or medication were not
following British National Formulary (BNF) guidance on titration in the
last 6 months
0.3 0.10, 0.92 0.035
12 Presence of anxiolytic medication
This is defined as having ‘anxiolytic medication’ as defined by BNF 4.1.2
Currently it is unclear how relevant a risk factor this is as it has not been
clearly defined
0.41 0.16, 1.05 0.06
13 Intellectual disability (ID)
Two case–control studies found ID to be a risk factor whereas two others did
not. In the combined analysis ID was not a significant risk factor The
incidence of SUDEP was higher among children with ‘‘complicated’’
epilepsy (with known structural brain lesion, intellectual disability) than
those without. Concerns exist on the way ID is described and cases
collected
2.5 0.66, 9.34 0.18
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position and increasing seizure frequency, which could be
ranked.
Conclusion
This is the first case-control study exploring the risk factors
for SUDEP since 2009. There were four major case control
studies looking at SUDEP risk factors [9–13] whose data
was pooled and a combined analysis of the identified risk
factors conducted in 2011 [9]. Our study supports many of
the pooled findings from those studies that certain factors
have a considerable impact upon the risk of SUDEP, and
importantly, a large proportion of these factors can be
modified. Some factors considered are new or are bearing
different results to the pooled analysis. This study finding
has been compared to the current evidence of a recent
major review on SUDEP risk factors (Table 2).
The four case control studies [10–13] while all trying to
enumerate risk factors were diverse in their design,
examination of population of risk and controls (Table 3).
Risk factor examination was more explorative in nature.
The pooled analysis [9] was a function of the results of
these studies. Our study unlike other SUDEP case control
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Fig. 1 Odds ratios for having
SUDEP given risk factor. Bars
represent 95 % CI. Solid circles
are significant factors after
sequential Bonferroni correction
Table 1 continued
Rank Factor and its description Odds ratio 95 % CI P value
14 Male gender
Was found a risk factor commonly in descriptive studies but has not been
replicated in controlled studies
0.62 0.29, 1.31 0.21
15 Depression treatment
This is defined as having clinical depression as per ICD 10/DSMV and/or
being on antidepressant medication’ as defined by BNF 4.3 and/or having
therapy/counseling for depression
Currently it is unclear how relevant a risk or a safety factor depression or its
treatment particularly SSRIs are. This is has not been clearly defined
0.74 0.31, 1.80 0.50
16 Carbamazepine
There is no significant association between use of carbamazepine and
SUDEP risk as per current evidence
1.10 0.51, 2.32 0.83
17 Increasing seizure severity
This is evidenced by an increase in the last 6 months of the administration of
rescue medication such as Midazolam, paramedic call outs or ED visits as
recorded in clinical notes
0.94 0.26, 3.40 0.92
Factors are ranked by P value. * indicates significant using a sequential Bonferroni correction for multiple comparisons with alpha = 0.05
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studies had a pre-designed questionnaire which had the
advantage of having extracted the risk factors of all the
other studies, in particular, the pooled analysis [9] and re-
testing it in a new population thus looking to see if the
factors identified by the pooled analysis were generally
applicable. The pooled analysis got its data from studies of
Table 2 Comparison between identified risk factors in the study and recently published review of risk factors for SUDEP
Risk factor Shankar et al. findings Tomson et al. [17, 18] review of risk factors
Sleeping in prone position Significant A risk factor requires more confirmation
Treatment history—unclear Significant Not considered in review
Generalized tonic–clonic epilepsy Significant Strong risk factor
Increasing seizure frequency Significant A risk factor
Compliance issues Significant Possible risk factor
Alcohol problem Significant Possible risk factor
Subtherapeutic AED levels Significant Unreliable as a risk factor
Night surveillance Significant A risk factor but requires more confirmation
Duration ([15 years) Significant A risk factor
Early onset epilepsy Close to significant—power might play a role A risk factor
Frequent AED changes Close to significant—power may play a role Not considered in review
Presence of anxiolytic medication Close to significant—power may play a role Not considered in review
Intellectual disability (ID) Not significant—confounder recognized Conflicting evidence on risk factor. Require more studies
Male gender Not significant A risk factor
Depression treatment Not significant Not considered in review
Carbamazepine Not significant Not a risk factor
Increasing seizure severity Not significant Not considered in review
Table 3 Details extracted from the pooled analysis study [9]
US study
[10]
Swedish study [13] Scottish study [12] English study [11] Our study
Rough time
period of
study
1991–1996 1980–1989 From 1982 all deaths till
near the study (2007)
1989–1998 2004–2012
Case to
controls mix
20 cases
and 80
controls
56 cases and
157 controls
64 cases and
119 controls
149 cases and
602 controls
48 cases and 220
controls
Case
description
SUDEP in
specialist
epilepsy
centers
Discharged from hospitals
diagnosis of epilepsy on
death certificates
Those registered with the
epilepsy unit
SUDEP were identified by
coroners, neurologists,
self-referred by family
members, and by the
charity Epilepsy
Bereaved
SUDEP in community
and being
representative of all
deaths in Cornwall
UK (pop: 600,000)
Case specifics Identified deaths between
15 and 70 years
16–50 years No age limit
Control
description
Controls
randomly
selected
For each case of SUDEP 3
living controls were
randomly drawn from
the study population and
matched on year of birth,
sex, and assessment
period
2 living controls were
randomly selected from
the Epilepsy Unit
population and matched
on year of birth, gender,
and syndrome
classification
4 controls with epilepsy
were randomly selected
from a diagnostic index
and a prescription
database and matched to
each SUDEP case
according to age and
geographic location
The control population
attended two specialist
epilepsy outpatient
clinics in Cornwall.
The population was a
continuous sample
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different geographic regions and demographics. The cur-
rent study observed if such a pooled result could be rep-
resentative in a new region with a well-defined population.
There are other advantages to our study too. Three of the
four past studies [10, 12, 13] were hospital centric with the
deaths being traced from hospital records and not com-
munity based. One of the four studies [11] collected
referrals from diverse streams but was not structured to
identify the full population at risk, and thus not systematic.
Our study has the advantage that controls and SUDEP were
drawn from the same population. Moreover, it is also the
only study where a pre-developed checklist has been used
in both the people who died and controls.
Poor accessibility of services or poor engagement with
services as indicated by an unclear treatment history, poor
adherence, increasing seizure frequency and subtherapeutic
medication levels increased the risk of being in the SUDEP
group. As previously found if patients misuse alcohol, they
add to their risk of SUDEP. If patients have night
surveillance through someone sleeping with them or using
a monitor, risk is reduced, as is sleeping in the non-prone
position. While the association of the ‘prone position’ is
strong and theoretically a modifiable risk factor the actual
and practical modifiability of this factor is contested.
People do not typically stay just prone in bed, while
sleeping they toss and turn. Patients with epilepsy typically
roll over when having seizures to turn their face into the
pillow. There might be a role for anti-asphyxia pillows
[14]. Night surveillance, while a practically achievable
issue, should take into account privacy issues and the
choice to live alone. A practical person-centered approach
to such social situations might pay dividends. All of these
factors can be addressed but require the patient to be
informed about SUDEP risks (an aim of the SUDEP
checklist).
As with the combined analysis [9] carbamazepine as a
risk factor was not significant thus further consolidating its
safety profile with regard to SUDEP. Interestingly being
male and taking antidepressants were not significant; this
may have been the result of an underpowered study but it
does indicate that these factors are probably not so critical.
The negative finding on intellectual disability (ID) is
difficult to interpret. Other studies have shown this to be a
risk factor of SUDEP [9, 10, 15, 16]. However, Cornwall
has a dedicated ID epilepsy service as approximately 25 %
of PWE have ID and our data suggest only 6.3 % of people
dying from SUDEP have an ID [4] compared to 23.4 % in
other studies [15]. It is possible that ID as a risk factor is
dependent on the quality of services rather than the ID
itself.
There are clear limitations to this study. The cases of
people dying from SUDEP were taken over 9 years
between 2004 and 2012. The controls were patients
attending specialist clinics between 2013 and 2014. How-
ever, the management of epilepsy has not changed radi-
cally over this period as reflected in the similar NICE
guidelines for the management of epilepsy published in
2004 and 2012. The 1st line drugs and many other strate-
gies for managing seizures remain pretty much the same. In
spite of being proposed as a NICE guidance since 2004 the
communication of the risk of SUDEP has been significantly
low in fact 4 % in 2013 [17]. Both the 2001 and 2011
national census confirms Cornwall is one of the poorest
parts of the United Kingdom in terms of per capita GDP
and average household incomes. They also reveal social
deprivation, ethnicity and migration rates (very low) have
not changed substantially. In fact, the same epilepsy teams
and personnel have been in place managing this same
population of PWE which has a low turnover. While all the
controls were from specialist clinics it is worth noting that
the highest risk patients were being compared. It can be
thus argued that the impact of the potential bias of the
various limitations emerging from the control group
selection is minimal.
Given that subtherapeutic drug levels may be a reflec-
tion of medication nonadherence, the two are by no means
independent of each other. The same is true for early onset
of epilepsy and prolonged ([15 years) duration of epilepsy
not necessarily mutually exclusive. Unfortunately, given
low numbers and missing data a logistic regression analysis
could not be performed.
The cases and controls were not matched samples. The
review of medical notes was not blind to the reviewers
which may be a source of bias, and the controls were
determined from outpatient clinics. However, this is the
first study where a structured application of a pre-designed
risk checklist to both the demised PWE and controls has
been done. Both sets were also drawn from the same at risk
epidemiological population, i.e., county of Cornwall
(population 550,000) UK. This has provided an opportunity
to rank the risk factors thus highlighting that SUDEP is not
only modifiable and multidimensional but likely to be
associated with different intensity and degrees of risk. It
again highlights that SUDEP could be a cumulative effect
of few or many of these risk factors, many modifiable and
possibly coming together in a ‘perfect storm’ to cause an
adverse outcome. There were two children under 15 in the
study. Some factors would not apply to children and others
might be less modifiable. Given the small numbers we do
not believe it would have influenced the outcome of our
study.
Overall, our study supports the use of an evidenced
based checklist to discuss potentially modifiable factors
with patients, especially to inform people of their person
centred risk of SUDEP. Cornwall Public Health and
coroner annual data show SUDEP deaths have reduced
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considerably in the last 2 years compared to previous
years, though given the small numbers involved and the
multiple variables these at best are early trends. It sits well
with the fact that of PWE and/or their carers administered
the checklist in the last 3 years in epilepsy clinics
(n = 400?) in Cornwall UK, 98 % of patients approved,
felt empowered and felt safer knowing person-centered risk
[5, 6]. There is anecdotal evidence to suggest it contributed
to improved compliance and adherence of medication and
more importantly contact with health services if problems
existed with the medication as opposed to generally stop-
ping it without advice. A structured approach may pay
dividends in focusing individuals on items in their locus of
control and may mitigate risk.
Acknowledgments Professor Torbjorn Tomson Department of
Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Compliance with ethical standards
Conflicts of interest JH, CN, FF, and RL report no conflicts. RS has
received institutional and research support and personal fees from
UCB, Eisai, Janssen, Lilly, GSK, Servier, Astra Zeneca and Desitin
outside the submitted work. MW has received institutional and per-
sonal fees from Eisai and UCB. BMcL has received research support
and personal fees from Eisai, UCB, GSK and Desitin outside the
current work.
Ethical standards All procedures involved in this study involving
human participants were in accordance with the institutional and
national research committees and with the 1964 Helsinki declaration
and its later amendments. For this retrospective study formal con-
senting was not required.
References
1. Duncan JS, Sander JW, Sisodiya SM et al (2006) Adult epilepsy.
Lancet 367:1087–1100
2. Tellez-Zenteno JF, Hern’andez Ronquillo L, Wiebe S (2005)
Sudden unexpected death in epilepsy: evidence-based analysis of
incidence and risk factors. Epilepsy Res 65:101–115
3. Shankar R, Cox D, Jalihal V et al (2013) Sudden unexpected
death in epilepsy (SUDEP): development of a safety checklist.
Seizure 22(10):812–817
4. Shankar R, Jalihal V, Walker M et al (2014) A community study
in Cornwall UK of sudden unexpected death in epilepsy
(SUDEP) in a 9-year population sample. Seizure 23(5):382–385
5. Shankar R, Newman C, McLean B, Anderson T (2015) Can
technology help reduce risk of harm in patients with epilepsy? Br
J Gen Pract 65(638):448–449
6. Shankar R, Newman C, Hanna J, Ashton J, Jory C, McLean B,
Anderson T, Walker M, Cox D, Ewins L (2015) Keeping patients
with epilepsy safe: a surmountable challenge? BMJ Qual Improv
Rep. doi:10.1136/bmjquality.u208167.w3252
7. https://www.sudep.org/checklist. Accessed 16 Apr 2016
8. Annegers JF, Coan SP (1999) SUDEP: overview of definitions
and review of incidence data. Seizure 8(6):347–352
9. Hesdorffer DC, Tomson T, Benn E et al (2011) Commission on
Epidemiology. Subcommission on mortality combined analysis
of risk factors for SUDEP. Epilepsia. 52(6):1150–1159
10. Walczak TS, Leppik IE, D’Amelio M et al (2001) Incidence and
risk factors in sudden unexplained death in epilepsy: a prospec-
tive cohort study. Neurology 56:519–525
11. Langan Y, Nashef L, Sander JW (2005) Case-control study of
SUDEP. Neurology 64:1131–1133
12. Hitiris N, Suratman S, Kelly K et al (2007) Sudden unexpected
death in epilepsy: a search for risk factors. Epilepsy Behav
10:138–141
13. Nilsson L, Farahmand BY, Persson P et al (1999) Risk factors for
sudden unexpected death in epilepsy: a case control study. Lancet
353:888–893
14. Catcheside P, Mohtar A, Reynolds K et al (2014) Airflow resis-
tance and CO2 rebreathing properties of anti-asphyxia pillows
designed for epilepsy. Seizure Eur J Epilepsy 23(6):462–467
15. Young C, Shankar R, Palmer J et al (2015) Does intellectual
disability increase sudden unexpected death in epilepsy (SUDEP)
risk. Seizure 25:112–116
16. Kiani R, Tyrer F, Jesu A et al (2013) Mortality from sudden
unexpected death in epilepsy (SUDEP) in a cohort of adults with
intellectual disability. J Intellect Disabil Res 58(6):508–520
17. Waddell B, McColl K, Turner C et al (2013) Are we discussing
SUDEP? A retrospective case note analysis. Seizure Eur J Epi-
lepsy 22(1):74–76
18. Tomson T, Surges R, Delamont R et al (2016) Who to target in
sudden unexpected death in epilepsy prevention and how? Risk
factors, biomarkers, and intervention study designs. Epilepsia
57(Suppl. 1):4–16
J Neurol
123
Author's personal copy
